Medication adherence and asthma control with once-daily indacaterol/glycopyrronium/mometasone (IND/GLY/MF) Breezhaler digital companion: interim analysis from Europe
H. Woehrle (Ulm, Germany), P. Mastoridis (East Hanover, NJ, United States), D. A Stempel (San Francisco, CA, United States), L. Kaye (San Francisco, CA, United States), V. Vuong (San Francisco, CA, United States), K. Mezzi (Basel, Switzerland)
Source: International Congress 2022 – Clinical treatment of asthma
Session: Clinical treatment of asthma
Session type: Thematic Poster
Number: 3862
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Woehrle (Ulm, Germany), P. Mastoridis (East Hanover, NJ, United States), D. A Stempel (San Francisco, CA, United States), L. Kaye (San Francisco, CA, United States), V. Vuong (San Francisco, CA, United States), K. Mezzi (Basel, Switzerland). Medication adherence and asthma control with once-daily indacaterol/glycopyrronium/mometasone (IND/GLY/MF) Breezhaler digital companion: interim analysis from Europe. 3862
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|